Osteoporosis: recognising those at risk

Key points

General practice has an important role to play in preventing the health burden associated with fractures.

Many people at high risk of osteoporotic fractures are not identified. Moreover many of these patients remain untreated, even after presenting with a minimal trauma fracture.

Initiate medicines in patients with a minimal trauma fracture or at higher risk of fracture to prevent future fractures.

Address issues with adherence to osteoporosis medicines and promote a healthy lifestyle that addresses modifiable risk factors for osteoporosis.

Osteoporosis is underrecognised and undertreated, even in people who present with a minimal trauma fracture.1-3

Fewer than 20% of patients presenting with minimal trauma fracture are investigated or treated for osteoporosis,1,2,4,5 with undertreatment of men a particular problem.6

Minimal trauma fracture increases the risk of future fractures

Following an initial minimal trauma fracture, the risk of repeat fractures is doubled.4,7 This is in addition to the increased risk associated with low bone mineral density (BMD).4 (Read about all the risk factors for fracture below.)

Higher 5-year mortality rates following repeat fractures

A study found that following an initial minimal trauma fracture, women and men with repeat fractures had higher 5-year mortality rates (39% and 51%, respectively) than people with no repeat fractures (26% and 37%, respectively).8

The risk of minimal trauma fracture, particularly hip fracture, increases steeply in older women and men.2,9,10 Highest absolute fracture risk (10% or worse in 3 years) is seen for postmenopausal women and men aged ≥ 70 years with T-scorea < –2.5 (in absence of fracture).2

A minimal trauma fracture is sufficient for a presumptive diagnosis of osteoporosis. Treatment with osteoporosis medicines can start prior to obtaining BMD results with dual energy X-ray absorptiometry (DXA).1,2,11-15

a T-score is the number of standard deviations from a young adult reference mean.

Clinical risk factors and their impact on fracture risk

Risk factors should be assessed16,17 and modifiable risk factors addressed1,2,10,18 in all postmenopausal women aged ≥ 45 years and men aged ≥ 50 years.16,17

Fracture risk increases with decreasing BMD, which is a well-known age-dependent risk factor.16,19 Other clinical risk factors (CRFs) further raise a person's risk of fracture (Figure 1).20-22 This means a 60-year-old man with a T-score of –1.0 and 4–6 risk factors would have a higher 10-year probability of hip fracture than a 70-year-old man with the same T-score and no risk factors other than age (Figure 1).

When assessing an individual’s absolute fracture risk, the relative contribution of these other clinical risk factors needs to be considered.20

Figure 1: 10-year probability of hip fracture based on FRAX data is dependent on age, BMD T-score and the presence of other clinical risk factors

Notes

b PBS defines vertebral fracture as ≥ 20% reduction in the height of the anterior or mid portion of a vertebral body relative to the posterior height of that body or ≥ 20% reduction in any of these heights compared to the vertebral body above or below the affected vertebral body.

c Defined as > 7.5 mg/day of prednisolone or equivalent for > 3 months. MBS subsidy applies only for patients taking this dose for at least 4 months.

d In people aged > 70 years, age is a sufficient risk factor to prompt BMD testing by DXA.

BMD testing by DXA is the gold standard for an osteoporosis diagnosis

DXA scanning is recommended for women aged > 50 years and men aged > 60 years with multiple risk factors for osteoporosis.1,2,26

DXA is the gold standard in Australia for obtaining BMD measures and can assist with diagnosis, monitoring and treatment decisions, and communicating these with patients.27

The WHO criteria utilising T-scores can be used to diagnose osteopenia and osteoporosis (Figure 2).1 Z-scoree is useful for evaluating bone loss in patients aged < 50 years.1,26 Actual BMD (g/cm2) is required for monitoring BMD changes over time.1,28

Figure 2: WHO diagnostic criteria for normal BMD, osteopenia and osteoporosis. Used with permission from Osteoporosis Australia - Health Professional Guide

Diagnosis should exclude secondary causes

Identify and treat underlying causes for osteoporosis or other medical conditions such as multiple myeloma and metabolic bone disease (eg, osteomalacia, renal bone disease) that may closely simulate osteoporosis.1,2

Laboratory tests are indicated after a minimal trauma fracture, if a patient’s medical history or examination suggests secondary causes, or if a patient's Z-score < –2.0.2

e Z-score is the number of standard deviations from an age- and sex-matched reference mean.

Expert reviewers

Associate Professor Vasi Naganathan, Centre for Education and Research on Ageing, University of Sydney. Ageing and Alzheimer's Institute, Concord Hospital, Sydney, NSW.

Date published: 30 September 2015Reasonable care is taken to provide accurate information at the time of creation. This information is not intended as a substitute for medical advice and should not be exclusively relied on to manage or diagnose a medical condition. NPS MedicineWise disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer. This website uses cookies. Read our privacy policy.